Heliosite is a range of implantable ports with a catheter allowing access to the central venous system.
Heliosite is supplied in a tray with double packaging containing :
- a titanium port encased in silicone. The upper part is a silicone membrane, the septum, which is punctured to administer drugs, parenteral nutrition solutions or to take blood samples
- 1 silicone catheter, detachable (codes 2217.116, 2218.116 and 2219.116) or pre-connected (codes 2217.126, 2218.126 and 2219.126) to the port with graduations every centimetre
- 1 peel-away Desilet introducer allowing a percutaneous placement of the catheter. The Desilet introducer is made up of a puncture needle with BLS valve (BloodLess System) to minimise blood loss and the risk of air embolism, a Nitinol J guidewire (particularly kink-resistant), a guide-advancer, a 10 ml syringe, a dilator/sheath assembly
- 1 tunnellisation needle
- 1 Inject-site needle 22G (for injection)
- 1 Hubsite, Huber needle (length : 22 mm) for infusion 20G (except codes 2217.116/126 : Hubsite 22G)
- 1 catheter guide
- 1 adapter for pressure transducer
- 1 female Luer-lock connector to prime the detachable catheter
Advantage of Heliosite ports codes 2217 (Extra-small model), 2218 (small model) and 2219 (medium model) :
- low profile ports – advantage : aesthetic aspect, comfort of the patient, with flat puncture area, without rim around the sectum (less traumatising for the skin), no cupping effect.
- less fibrotic effect facilitating the removal of the port.